P

Inventor

ZHAO QIAN

US183 patents
⚠️ This page may combine multiple inventors who share the name “ZHAO QIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARRAY BIOPHARMA INC

16 patents
US9493476B2Nov 15, 2016

Macrocyclic compounds as trk kinase inhibitors

ARRAY BIOPHARMA INC46 citations98
US7449486B2Nov 11, 2008

Mitotic kinesin inhibitors and methods of use thereof

ARRAY BIOPHARMA INC37 citations96
US9902741B2Feb 27, 2018

Macrocyclic compounds as TRK kinase inhibitors

ARRAY BIOPHARMA INC22 citations94
US9840519B2Dec 12, 2017

Macrocyclic compounds as TRK kinase inhibitors

ARRAY BIOPHARMA INC21 citations94
US9750744B2Sep 5, 2017

Macrocyclic compounds as Trk kinase inhibitors

ARRAY BIOPHARMA INC21 citations94
US9718822B2Aug 1, 2017

Macrocyclic compounds as Trk kinase inhibitors

ARRAY BIOPHARMA INC22 citations94
US7777032B2Aug 17, 2010

Quinazoline analogs as receptor tyrosine kinase inhibitors

ARRAY BIOPHARMA INC11 citations92
US7585975B2Sep 8, 2009

Quinazoline analogs as receptor tyrosine kinase inhibitors

ARRAY BIOPHARMA INC11 citations92
US7501427B2Mar 10, 2009

Quinazoline analogs as receptor tyrosine kinase inhibitors

ARRAY BIOPHARMA INC14 citations92
US9693989B2Jul 4, 2017

N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

ARRAY BIOPHARMA INC13 citations91
US10647730B2May 12, 2020

Macrocyclic compounds as TRK kinase inhibitors

ARRAY BIOPHARMA INC4 citations84
US7956073B2Jun 7, 2011

Mitotic kinesin inhibitors and methods of use thereof

ARRAY BIOPHARMA INC8 citations84
US9221841B2Dec 29, 2015

Mitotic kinesin inhibitors and methods of use thereof

ARRAY BIOPHARMA INC5 citations83
US7795282B2Sep 14, 2010

Mitotic kinesin inhibitors and methods of use thereof

ARRAY BIOPHARMA INC9 citations83
US7452895B2Nov 18, 2008

Quinazoline analogs as receptor tyrosine kinase inhibitors

ARRAY BIOPHARMA INC14 citations83
US10780073B2Sep 22, 2020

N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

ARRAY BIOPHARMA INC7 citations82

BRISTOL MYERS SQUIBB CO

6 patents

HANS JEREMY

4 patents

WANG TAO

2 patents

NOVARTIS AG

2 patents

WALLACE ELI

2 patents

CAFERRO THOMAS RAYMOND

2 patents

ANDREWS STEVEN WADE

1 patent

BEIJING LENOVO SOFTWARE LTD

1 patent

CALIFORNIA INST OF TECHN

1 patent

LANSUS TECH INC

1 patent

BOCIAN DAVID F

1 patent

UNIV CALIFORNIA

1 patent

CHILDREN'S NAT MEDICAL CENTER

1 patent

LYSSIKATOS JOSEPH P

1 patent

MIRATI THERAPEUTICS INC

1 patent

FUJITSU LTD

1 patent

LEGEND HOLDINGS LTD

1 patent

UNIV NANJING POSTS & TELECOMMUNICATIONS

1 patent

GEN ELECTRIC

1 patent

SHENZHEN KEYA MEDICAL TECH CORPORATION

1 patent

MAZDA MOTOR

1 patent

LENOVO BEIJING CO LTD

1 patent

Showing the top 50 of 183 patents by PatentIndex Score.